Home

šokující Velký dub Sklad marker ck20 cítit Zatknout Přidání

A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown  primary using circulating tumor cells. - Abstract - Europe PMC
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells. - Abstract - Europe PMC

Summary of predominant CK 7/CK 20 immunophenotype of feline and canine... |  Download Table
Summary of predominant CK 7/CK 20 immunophenotype of feline and canine... | Download Table

Pathology Outlines - Cytokeratin 20 (CK20, K20)
Pathology Outlines - Cytokeratin 20 (CK20, K20)

Pathology Outlines - Cytokeratin 20 (CK20, K20)
Pathology Outlines - Cytokeratin 20 (CK20, K20)

Immunohistochemical Profile for Unknown Primary Adenocarcinoma | PLOS ONE
Immunohistochemical Profile for Unknown Primary Adenocarcinoma | PLOS ONE

The value of CDX2 and cytokeratins 7 and 20 expression in differentiating  colorectal adenocarcinomas from extraintestinal gastrointestinal  adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2  antibody | Diagnostic Pathology | Full Text
The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody | Diagnostic Pathology | Full Text

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial  carcinomas of the upper urinary tract with a poor prognosis | PLOS ONE
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis | PLOS ONE

Interpretation of TTF-1, CK7 and CK20
Interpretation of TTF-1, CK7 and CK20

Cytokeratin 20 Antibody - Biocare Medical
Cytokeratin 20 Antibody - Biocare Medical

Diagnostic accuracy of SATB2 in identifying primary and metastatic  colorectal carcinoma: a comparative immunohistochemical study - ecancer
Diagnostic accuracy of SATB2 in identifying primary and metastatic colorectal carcinoma: a comparative immunohistochemical study - ecancer

PathPlus™ KRT20 / CK20 / Cytokeratin 20 Polyclonal Antibody IHC | LSBio
PathPlus™ KRT20 / CK20 / Cytokeratin 20 Polyclonal Antibody IHC | LSBio

PathPlus™ KRT20 / CK20 / Cytokeratin 20 Monoclonal Antibody IHC | LSBio
PathPlus™ KRT20 / CK20 / Cytokeratin 20 Monoclonal Antibody IHC | LSBio

The diagnostic algorithm for workup of a CK7−/CK20+ carcinoma. | Download  Scientific Diagram
The diagnostic algorithm for workup of a CK7−/CK20+ carcinoma. | Download Scientific Diagram

IVD Antibody Development Services for CK20 Marker - Creative Biolabs
IVD Antibody Development Services for CK20 Marker - Creative Biolabs

A combination of the immunohistochemical markers CK7 and SATB2 is highly  sensitive and specific for distinguishing primary ovarian mucinous tumors  from colorectal and appendiceal metastases | Modern Pathology
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases | Modern Pathology

Differential expression of CK7, CK20, CDX2 in intestinal and  pancreatobiliary types of preriampullary carcinoma Sree UD, Prayaga AK, R.  Reddy V V, Rukmanghadha N, Chowhan AK, Phaneendra B V - Indian J Pathol  Microbiol
Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma Sree UD, Prayaga AK, R. Reddy V V, Rukmanghadha N, Chowhan AK, Phaneendra B V - Indian J Pathol Microbiol

Diagnostics | Free Full-Text | Anti-CK7/CK20 Immunohistochemistry Did Not  Associate with the Metastatic Site in TTF-1-Negative Lung Cancer
Diagnostics | Free Full-Text | Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer

PDF] Expression of cytokeratin 7 and 20 in pathological conditions of the  bile tract. | Semantic Scholar
PDF] Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract. | Semantic Scholar

IVD Antibody Development Services for CK20 Marker - Creative Biolabs
IVD Antibody Development Services for CK20 Marker - Creative Biolabs

Pathology Outlines - Cytokeratin 20 (CK20, K20)
Pathology Outlines - Cytokeratin 20 (CK20, K20)

Additional file 1: of Detection of circulating tumor cells with CK20 RT-PCR  is an independent negative prognostic marker in colon cancer patients – a  prospective study
Additional file 1: of Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients – a prospective study

March 2012 Residency Program Case of the Month | Department of Pathology UC  Davis Health System
March 2012 Residency Program Case of the Month | Department of Pathology UC Davis Health System